Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Sumitomo Pharma Co., Ltd. (DNPUF)
Market Closed
10 Aug, 20:00
OTC PINK
All
(7)
DE
(4)
TW
(1)
JP
(1)
US
(1)
JPX
Primary
TWSE
OTC PINK
XFRA
XDUS
XMUN
XSTU
$
8.
41
0
0%
$
4.55B
Market Cap
-
P/E Ratio
0.11%
Div Yield
118
Volume
0
Eps
$
8.41
Previous Close
Watching
Watch
Add Transaction
Day Range
8.41
8.41
Year Range
7.24
19.2
Want to track
DNPUF
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Earnings
Splits
Statistics
Historical Data
Sumitomo Pharma Co., Ltd. (DNPUF) Statistics
Valuation metrics
Market Cap
4.55B
Enterprise value
664.95B
Trailing P/E (ttm)
4.63
Forward P/E
-
PEG ratio
0.01
Price/Sales (ttm)
1.22
Price/Book (mrq)
1.38
Enterprise Value/Revenue
1.4
Enterprise Value/EBITDA
5.04
Overview
Shares outstanding
397.29M
Float
183.3M
Shares short
-
% Held by insiders
0.55%
% Held by institutions
0.18%
Average volume (10 days)
73
Average volume (90 days)
136
Price summary
52-Week low
7.24
52-Week high
19.2
Beta
0.6
50-Day moving average
8.85
200-Day moving average
11.49
Dividends and splits
Forward annual dividend rate
0.11
Forward annual dividend yield
0.0073%
Trailing annual dividend rate
0.15
Trailing annual dividend yield
0.0104%
5-Year annual dividend yield
-
Payout ratio
0
Dividend Date
28 Jun 2023
Ex-Dividend Date
30 Mar 2023
Last split factor
21:20
Last split Date
26 Mar 1992
Financials
Fiscal year
Fiscal year ends
31 Mar 2025
Most recent quarter (mrq)
30 Jun 2025
Profitability
Profit margin
0.24%
Operating margin
0.1%
Operational effectiveness
Return on assets
0.13%
Return on equity
0.36%
Income Statement
Revenue (ttm)
2.85B
Revenue per share (ttm)
1,089.9
Quarterly revenue growth (yoy)
0.07%
Gross profit (ttm)
1.69B
EBITDA
56.67B
Net income to common (ttm)
691.93M
Diluted EPS (ttm)
258.61
Quarterly earnings growth (yoy)
-0.83%
Balance Sheet
Total cash (mrq)
360.28M
Total cash per share (mrq)
175.93
Total debt (mrq)
1.63B
Total Debt/Equity (mrq)
0.39
Current ratio (mrq)
1.21%
Book value per share (mrq)
937.86
Cash Flow
Cash flow statement
334.85M
Levered free cash flow (LFCF)
253.28M